Close Menu

Biofidelity: Heiner Dreismann

Sep 10, 2020

Biofidelity has appointed Heiner Dreismann as the firm's chairman. Prior to Biofidelity, Dreismann served as president and CEO of Roche Molecular Systems. He currently serves on the board of several public and private life sciences and healthcare firms in the US, Europe, and Israel. 

More Like This

Nov 23, 2020

Thermo Fisher Scientific: Alexandra Keith

Alexandra Keith has been elected to the board of directors of Thermo Fisher Scientific. She is the CEO of Procter & Gamble's global beauty business and a member of P&G's global leadership council. Over the past 30 years, she has served in a variety of roles at P&G, including in manufacturing, logistics, communications, and product innovation.

Nov 20, 2020

Congenica: Sam Roberts

Sam Roberts has been appointed as a non-executive board director of Congenica. She is the managing director of Health & Care at Legal & General, which co-led Congenica's recent $50 million Series C funding round. Previously, she was the chief executive of the Accelerated Access Collaborative, an umbrella organization for UK health innovation. She also used to be director of innovation, research, and life sciences at NHS England. Roberts holds an MBA from the Australian Graduate School of Management and a doctorate in evidence-based healthcare from the University of Oxford.

Nov 20, 2020

Omniome: Robert Wicke

Omniome has appointed Robert Wicke as CEO. He is also joining the San Diego-based sequencing technology company's board of directors. Wicke comes to Omniome from Halo Labs, where he was CEO. Previously, he held executive leadership positions at ForteBio, Pall, Molecular Devices, and Axon Instruments.

Nov 19, 2020

Icahn School of Medicine at Mount Sinai: Alison Goate

Alison Goate has been named chair of the department of genetics and genomics sciences at the Icahn School of Medicine at Mount Sinai, effective Jan. 1, 2021.

Goate is the Willard T.C. Johnson research professor of neurogenetics and a professor of genetics and genomic science, neuroscience, and neurology. Her research focuses on genetic risk factors of neurodegenerative diseases, including Alzheimer's disease and frontotemporal dementia.

She came to Mount Sinai in 2015 as founding director of the Ronald M. Loeb Center for Alzheimer's Disease and is a member of the National Academy of Medicine and a fellow of the American Association for the Advancement of Science. Goate holds a doctorate from the University of Oxford.

Nov 19, 2020

Natera: Monica Bertagnolli

Monica Bertagnolli has been appointed to the board of directors of Natera. She is a professor of surgery at Harvard Medical School and associate surgeon in the division of surgical oncology at Brigham and Women's Hospital and Dana-Farber Cancer Institute. In addition, she is the CEO of Alliance Foundation Trial, a nonprofit organization that conducts international cancer clinical trials, as well as VP of the Coalition of Cancer Cooperative Groups. Bertagnolli holds an undergraduate degree in engineering from Princeton University and a medical degree from the University of Utah College of Medicine.

Nov 18, 2020

PierianDx: Mark McDonough

PierianDx has hired Mark McDonough as CEO. McDonough, who has also joined the company's board of directors, takes over from Chairman and interim CEO Joe Boorady. The previous permanent CEO, Michael Sanderson, left PierianDx in April. McDonough previously was president and CEO of immunogenomics startup Immunis.AI. He also led CombiMatrix through that firm's 2017 acquisition by Invitae.

Nov 18, 2020

Quanterix: William Geist

Quanterix has named William Geist as chief operating officer. Geist most recently served as vice president and general manager for two of Thermo Fisher Scientific's protein and cell analysis and qPCR business units. He also held a key leadership role in Thermo Fisher's COVID-19 task force in its biosciences division. Prior to this, Geist held numerous sales, marketing, and business development leadership roles including vice president of sales, marketing, and business development at Qiagen's Quanta BioSciences. He holds a BA in biology from Dartmouth College.

Nov 17, 2020

Day Zero Diagnostics: Dekel Gelbman, Robin Patel, Sally Hojvat

Day Zero Diagnostics has appointed Dekel Gelbman as senior VP of business development and strategy, Robin Patel as a member of its scientific advisory board, and Sally Hojvat as a regulatory strategy advisor.

Gelbman joins the company from FDNA, where he was the founding CEO. Before that, he was a corporate and transactional attorney in Israel and the US.

Patel is the director of the infectious diseases research laboratory and co-director of the clinical bacteriology laboratory at the Mayo Clinic.

Hojvat is a senior consultant at Partners in Diagnostics. Prior to that, she was the director of the division of microbiology devices at the Center for Devices and Radiological Health at the US Food and Drug Administration.

Nov 17, 2020

Veracyte: John Hanna, Morten Frost

Veracyte has appointed John Hanna as its general manager of endocrinology, breast cancer, and lymphoma; and Morten Frost as its general manager of pulmonology. The firm has established the general manager structure as part of its plans for global expansion.

Hanna currently serves as Veracyte's chief commercial officer. Prior to Veracyte, Frost most recently held the role of head of global marketing for pathology and companion diagnostics at Agilent Technologies.

Nov 17, 2020

Inivata: Alan Schafer

Inivata has appointed Alan Schafer as its chief technology officer. Schafer previously served as CEO of 14M Genomics, a cancer molecular diagnostic firm. Prior to 14M Genomics, he served as CEO of Population Genetics. He has also served as global VP of technology development at GlaxoSmithKline and VP of genetics at Incyte. 

Nov 17, 2020

Sophia Genetics: Bram Goorden

Sophia Genetics has hired Bram Goorden as chief commercial officer and head of North American operations. Goorden, who will oversee expansion of the firm's global reach, joins Sophia from Foundation Medicine, where he was VP of international business and partnering. He previously served as general manager and head of therapeutics for Prometheus Laboratories.

Nov 16, 2020

Inteliquet: Tandy Tipps

Inteliquet has appointed Tandy Tipps as senior vice president of healthcare organizations solutions. In this role, Tipps will focus on advancing a site-centric approach to patient matching for clinical trials and precision medicine through a combination of technology, analytics, and clinical research expertise. Tipps previously developed and led the Oncology Site Network at Precision for Medicine. She also previously served as administrative director of a Phase I clinical trial program at the University of Texas MD Anderson Cancer Center.

Nov 13, 2020

Centogene: Jonathan Sheldon

Jonathan Sheldon has been nominated as a member of the supervisory board of Centogene. He will serve as an interim member with immediate effect until his confirmation at an upcoming shareholder meeting. Sheldon is senior VP of the digital insights business area at Qiagen and has led Qiagen's Digital Insights global business since 2018. Prior to this, he was global VP at Oracle Health Sciences.

Nov 10, 2020

Spartan Bioscience: Roger Eacock, Others

Spartan Bioscience, a Canadian company specializing in portable molecular diagnostic testing, has announced several new executive and board appointments. Roger Eacock joins the company as its new CEO and board member. Eacock has previously held leadership roles with companies such as TerrAscend, Sobeys, SunOpta, and Dell.

Eacock's appointment follows the election of three new members to Spartan's board of directors. Board Chair Rochelle Stenzler is a pharmacist with extensive experience as a senior executive in healthcare, retailing, consumer packaged goods, and interactive voice response technology. She has previously served as president of Revlon Canada and president and general manager of Pharma Plus Drugmarts.

Board member Arun Menawat is CEO of Profound Medical, which is developing a real-time MRI-guided thermal ultrasound system for incision-free ablation of abnormal or cancerous tissue. He is also former president and CEO of Novadaq Technologies.

Board member Maryscott Greenwood is partner and managing director of Crestview Strategy US, a public affairs consultancy. She is also CEO of the Canadian American Business Council.

Additionally, Lennie Ryer joins Spartan as CFO with more than 20 years of experience as CFO of several biotechnology companies including SQI Diagnostics and ConjuChem; and Trevor Brown joins Spartan as chief commercial officer, having previously served as vice president of precision medicine for Seracare Lifesciences and director of global strategic marketing at Luminex Molecular Diagnostics.

Finally, Jennifer Ross-Carriere has joined Spartan as chief legal and administrative officer. Ross-Carriere most recently served as general counsel, corporate secretary, and vice president, people and culture at IFS (previously Mxi Technologies).

Nov 06, 2020

Fluidigm: Puneet Suri

Fluidigm President and CEO Chis Linthwaite said during the company's third quarter earnings call that Puneet Suri has been named chief digital officer at Fluidigm. Suri has previously served as vice president, smart lab and digital science at Thermo Fisher Scientific, according to his LinkedIn profile. Prior to that he was senior director of software engineering at Life Technologies, which was acquired by Thermo Fisher, and before that, he spent a decade as a software development engineer and manager at Life Technologies predecessor Applied Biosystems.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.